The experts who attended
Dedicated professionals committed to clinical excellence.
Meet Southern Star Research at the Australian Dementia Research Forum 2026
Southern Star Research is proud to attend the Australian Dementia Research Forum (ADRF) 2026, one of Australia’s leading events focused on dementia, neuroscience, and healthcare innovation.
Bringing together researchers, clinicians, healthcare professionals, industry leaders and consumers, ADRF provides an important platform for advancing collaboration and accelerating progress in dementia research and neurological care. The forum highlights the latest developments in clinical research, translational science and emerging therapies aimed at improving outcomes for patients living with neurodegenerative conditions.
Why Connect With Southern Star Research?
At Southern Star Research, we partner with biotechnology, pharmaceutical and medical device companies to deliver high-quality clinical development programs with agility, insight and precision.
With deep expertise in central nervous system (CNS) research, our team supports sponsors navigating the complexities of neurological and neurodegenerative clinical trials across Australia and the Asia-Pacific region.
Whether you are planning an early-phase CNS study, exploring innovative dementia therapies, or seeking a strategic CRO partner with strong regional capabilities, we welcome the opportunity to connect during ADRF 2026.
CNS Clinical Research Experience
Our CNS experience spans a broad range of neurological and neurodevelopmental conditions, including:
- Alzheimer’s disease
- Chronic pain and neuropathic pain
- Epilepsy and developmental epileptic encephalopathy
- Migraine
- Myopathy
- Neurocognition studies
- Parkinson’s disease
- Tuberous sclerosis complex
Our team understands the operational and scientific complexities associated with CNS research, including patient recruitment challenges, endpoint selection, caregiver engagement, and long-term study management. We work collaboratively with sponsors and sites to deliver studies with rigor, responsiveness and quality at every stage.
How We Accelerate Your Clinical Development
- Proactive Partnership: We commit to engaging intellectually and energetically with our clients’ challenges. Our teams apply foresight, critical thinking and domain expertise to anticipate obstacles and contribute meaningfully to the trial’s success.
- Embedded Quality: We define quality not just by compliance, but by the consistent application of judgment, rigor, and thoughtful planning throughout all stages of the clinical trial process.
- Tailored Execution: Our flexible, hands-on approach means your study is designed for both scientific and commercial success – tailored to your strategy, timelines and endpoints.
As the most complete mid-sized CRO in the APAC region , our team brings deep therapeutic experience, strong regulatory awareness, and longstanding site relationships to support your first-in-human, first-in-patient or Phase 2 study. We focus on delivering high-quality data that not only meets international regulatory standards—including the FDA, EMA, PMDA and Health Canada—but also strengthens your path to partnerships, licensing and future funding.
Recognised Industry Leadership
Southern Star Research continues to be recognised for excellence across the clinical research industry, including:
- Best CRO in Australia 2026
- Great Place to Work Certified 2024 and 2025
- APAC CRO of the Year 2025
- NSW Exporter of the Year 2025
- Frost & Sullivan Asia-Pacific Competitive Strategy Leadership Award 2024
- ISO 9001 Quality Assurance 2024 and 2025
Meet Our Team at ADRF 2026
We look forward to connecting with sponsors, research partners and industry leaders throughout the conference.
To arrange a meeting with the Southern Star Research team during ADRF 2026, contact us to schedule a conversation.